April 15, 1998 The Honorable Donna Shalala Secretary Department of Health and Human Services 200 Independence Ave, SW Washington, D.C. 20201 Dear Secretary Shalala, At the Eleventh International Conference on AIDS in Vancouver over a year ago, you announced that the National Institutes of Health would spend $100 million over the next four years on research aimed at developing a safe and effective vaginal microbicide. As women have become the fastest growing group infected with HIV internationally and this disease is serious cause of morbidity and mortality in our community, we are extremely encouraged by your announcement. Although condoms and HIV/AIDS education campaigns have benefited some individuals at risk for AIDS, these methods have not stopped the epidemic. The development of safe and effective microbicides will give women, as well as some gay men, the ability to protect themselves against HIV and other sexually transmitted diseases (STDs) without fear of abuse and condemnation. While we are heartened that money has been allocated for the development of this critical product, we are concerned that at the current pace of the research, millions more people will die because they lack a viable method for prevention. Large pharmaceutical companies have expressed little interest in pursuing micribicide research. Furthermore, very few potential microbicide products besides nonoxynol- 9 have even reached Phase I clinical trials. In order to get safe and effective microbicides developed and on the market as soon as possible, more products need to be evaluated. Ideally, as with the development of HIV/AIDS treatments, multiple products should be examined consecutively in clinical trials. As you know, microbicides need to be available in a variety of formulations, such as gels, foams, and films in order to be effective and acceptable for the greatest number of people. We are writing to ask that you encourage the active collaboration between public and private sector institutions, including Universities, State and Federal laboratories, Schools of Public Health, and small biotech companies, both for the development and formulation of new products and for the implementation of clinical trials and acceptability studies. It is critical that microbicide research is accelerated and that the numerous institutions that have the ability to work on their development are encouraged to pursue this research. While research protocols that go through the standard Request For Proposal (RFP) routes are appropriate for many types of research, research that goes through this process can often take months and sometimes years to get administratively approved. Clearly for the development of products for HIV prevention, these delays can cost the lives of millions. We ask that you consider an expedited process for this research, perhaps through contracting specific research institutions or biotech companies or through creating incentives to private pharmaceutical companies to develop and market microbicides. The Food and Drug Administration should be asked to 'fast track' AIDS prevention methods, such as microbicides, in the way it has treatments and to look at ways to encourage pharmaceutical companies to develop microbicides. We also believe that international cooperation will be essential to secure success in this field. We thank you again for addressing the need for women-controlled methods of HIV prevention. The development of such methods will provide women and some men an additional tool to protect themselves against infection from HIV and other STDs. Clearly, the rapid development and availability of these products will save countless numbers of lives throughout the world. Sincerely, ___________________________ Shirley Dean, Mayor of Berkeley _____________________________________ Linda Maio, Berkeley City Councilmember _______________________________________ Margaret Breland, Berkeley City Councilmember _______________________________________ Maudelle Shirek, Berkeley City Councilmember _______________________________________ Dona Spring, Berkeley City Councilmember ________________________________________ Diane Wolley, Berkeley City Councilmember _________________________________________ Betty Olds, Berkeley City Councilmember __________________________________________ Kriss Worthington, Berkeley City Councilmember __________________________________________ Polly Armstrong, Berkeley City Councilmember